SAAMIA HOSSAIN MD
Prescription History 1710410121
Internal Medicine - Critical Care Medicine in Plainsboro, NJ

Active since April 04, 2017PECOS EnrolledAccepts Medicare Assignment
89.32/100
CMS Quality Rating
5 PLAINSBORO RD STE 300, PLAINSBORO, NJ 08536(609) 853-7272(609) 853-7271 Get Directions

NPPES record last updated: September 26, 2022. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Sep 26, 2022, Jul 6, 2021, Jun 17, 2021 (3 updates tracked since 2021).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SAAMIA HOSSAIN MD, an active Critical Care Medicine specialist practicing in Plainsboro, NJ. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 257 documented patient claims. Among these therapy options, the most frequently utilized medication is Budesonide-Formoterol Fumarate, which accounts for 57 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

9
Medications
257
Total Claims
291
30-Day Fills
Budesonide-Formoterol Fumarate
Most Prescribed · 57 claims
View details
9 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by SAAMIA HOSSAIN MD in 2024, with prescription volumes, average cost per fill, and NJ state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other NJ PrescribersVs. NJ Avg

About Budesonide-Formoterol Fumarate: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section.

In 2024, this provider wrote 57 Medicare prescriptions for Budesonide-Formoterol Fumarate, about 2.5 times the volume of the typical New Jersey prescriber of this medication (23.2). Medicare paid an average of $186.94 per fill, versus $216.47 statewide.

How often this provider prescribes it

This provider
57
NJ average
23.2

This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$186.94
NJ average
$216.47

This provider's average cost per fill is below the NJ average for this medication.

66
30-Day Fills
standardized to 30-day supplies
1,980
Days of Medication
total across all patients in 2024

About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾

This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2024, this provider wrote 47 Medicare prescriptions for Breo Ellipta, about 1.2 times the volume of the typical New Jersey prescriber of this medication (39.2). Medicare paid an average of $387.94 per fill, versus $515.53 statewide.

How often this provider prescribes it

This provider
47
NJ average
39.2

This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$387.94
NJ average
$515.53

This provider's average cost per fill is below the NJ average for this medication.

49
30-Day Fills
standardized to 30-day supplies
1,470
Days of Medication
total across all patients in 2024

About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾

It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.

In 2024, this provider wrote 36 Medicare prescriptions for Albuterol Sulfate Hfa, about half the volume of the typical New Jersey prescriber of this medication (67.2). Medicare paid an average of $26.73 per fill, versus $29.58 statewide.

How often this provider prescribes it

This provider
36
NJ average
67.2

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$26.73
NJ average
$29.58

This provider's average cost per fill is below the NJ average for this medication.

40.2
30-Day Fills
standardized to 30-day supplies
968
Days of Medication
total across all patients in 2024

About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2024, this provider wrote 36 Medicare prescriptions for Symbicort, about 1.5 times the volume of the typical New Jersey prescriber of this medication (24). Medicare paid an average of $232.52 per fill, versus $301.46 statewide.

How often this provider prescribes it

This provider
36
NJ average
24.0

This provider prescribes this medication more often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$232.52
NJ average
$301.46

This provider's average cost per fill is below the NJ average for this medication.

43
30-Day Fills
standardized to 30-day supplies
1,290
Days of Medication
total across all patients in 2024

About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2024, this provider wrote 22 Medicare prescriptions for Fluticasone-Salmeterol, about 67% of the volume of the typical New Jersey prescriber of this medication (32.9). Medicare paid an average of $154.57 per fill, versus $156.69 statewide.

How often this provider prescribes it

This provider
22
NJ average
32.9

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$154.57
NJ average
$156.69

This provider's average cost per fill is below the NJ average for this medication.

26
30-Day Fills
standardized to 30-day supplies
780
Days of Medication
total across all patients in 2024

About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed.

In 2024, this provider wrote 17 Medicare prescriptions for Trelegy Ellipta, about a quarter of the volume of the typical New Jersey prescriber of this medication (70.2). Medicare paid an average of $787.56 per fill, versus $837.87 statewide.

How often this provider prescribes it

This provider
17
NJ average
70.2

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$787.56
NJ average
$837.87

This provider's average cost per fill is below the NJ average for this medication.

21
30-Day Fills
standardized to 30-day supplies
630
Days of Medication
total across all patients in 2024

About Spiriva Respimat: Tiotropium is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾

It must be used regularly to prevent wheezing and shortness of breath. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

In 2024, this provider wrote 15 Medicare prescriptions for Spiriva Respimat, about half the volume of the typical New Jersey prescriber of this medication (31.1). Medicare paid an average of $515.90 per fill, versus $722.33 statewide.

How often this provider prescribes it

This provider
15
NJ average
31.1

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$515.90
NJ average
$722.33

This provider's average cost per fill is below the NJ average for this medication.

15
30-Day Fills
standardized to 30-day supplies
450
Days of Medication
total across all patients in 2024

About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾

It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

In 2024, this provider wrote 14 Medicare prescriptions for Wixela Inhub, about 65% of the volume of the typical New Jersey prescriber of this medication (21.6). Medicare paid an average of $148.17 per fill, versus $152.83 statewide.

How often this provider prescribes it

This provider
14
NJ average
21.6

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$148.17
NJ average
$152.83

This provider's average cost per fill is below the NJ average for this medication.

18
30-Day Fills
standardized to 30-day supplies
540
Days of Medication
total across all patients in 2024

About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾

Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease.

In 2024, this provider wrote 13 Medicare prescriptions for Ofev, about half the volume of the typical New Jersey prescriber of this medication (29). Medicare paid an average of $12,813.99 per fill, versus $13,068.24 statewide.

How often this provider prescribes it

This provider
13
NJ average
29.0

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12,813.99
NJ average
$13,068.24

This provider's average cost per fill is below the NJ average for this medication.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2024
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average NJ prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NJ average cost per fill.

About this data. The prescription history for SAAMIA HOSSAIN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Critical Care Medicine prescribing approach at this Plainsboro, NJ practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NJ prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.